Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany

We analysed trends over time in palliative first-line chemotherapy in patients with locally advanced or metastatic esophagogastric cancer. Special focus was on frequency and quality of HER2-testing and trends in drug use in combination with trastuzumab. Earlier published data about patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Merx, Kirsten, Barreto Miranda, Manuel, Kellermann, Lenka, Mahlknecht, Ulrich, Lange, Oliver, Gonnermann, Michael, Hofheinz, Ralf-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749805/
https://www.ncbi.nlm.nih.gov/pubmed/26941786
http://dx.doi.org/10.1155/2016/1028505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749805/
https://www.ncbi.nlm.nih.gov/pubmed/26941786
http://dx.doi.org/10.1155/2016/1028505

Ejemplares similares